Emma Gray BSc, MSc, PhD

Emma is Head of Clinical Trials at the MS Society. She is responsible for developing and supporting the MS Society’s growing portfolio of clinical trials; collaborating with national and international funders (charity, government, other) to secure funding for MS clinical trials, the UK MS Clinical Trials Network; and more recently the Expert Consortium on Progression in MS Clinical Trials. Before joining the MS Society, she gained a PhD in molecular neuroscience and worked as a post-doctoral researcher at the MRC Centre for Neurodegeneration Research (Institute of Psychiatry, King’s College London) focusing on molecular and cellular processes associated with neurodegeneration in Alzheimer’s disease.